510(k) Report

510(k) · Cleared

Cleared

Natural Hip System

K960258510(k) TraditionalCleared Jul 12, 1996176-day reviewClass II21 CFR 888.3350

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Intermedics Orthopedics · JDI Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented

Cleared on Jul 12, 1996 as substantially equivalent to K894051 (Intermedics Orthopedics, 1989) after a 176-day review. Its family tree reaches back 1 generation to 1989. 6 later devices descend from it.

Decided
Jul 12, 1996
Review
176 days
Class
Class II
Product code
JDI
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K894051 (1989). 6 later devices descend from it, 1 citing it directly.

Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 2 descendants3 generations forward: 3 descendants K894051 · Premier-Total Hip · Intermedics Orthopedics · 19890
  1. Root · 1 generation backK894051 Premier-Total HipIntermedics Orthopedics · 1989
  2. This deviceK960258 Natural Hip SystemIntermedics Orthopedics · 1996
  3. Descendant · cites it directly · 5 of its ownK172857 Latitud Hip Replacement SystemMeril Healthcare Pvt., Ltd. · 2018
  4. Descendant · 2 generations on · 3 of its ownK180973 Libertas Hip Replacement SystemMaxx Orthopedics, Inc. · 2018
  5. Descendant · 3 generations on · 0 of its ownK253171 Libertas Taper Short (TS) Uncemented Femoral Stem (Libertas TS Stem)Maxx Orthopedics, Inc. · 2026
  6. Descendant · 2 generations on · 0 of its ownK222436 Latitud™ Hip Replacement SystemMeril Healthcare Pvt., Ltd. · 2023
  7. Descendant · 3 generations on · 0 of its ownK192989 Libertas E-XLPE Modular LinerMaxx Orthopedics, Inc. · 2020

Showing 5 of 6 descendants. See all descendants

Descendants cleared per year

2018: 22019: 12020: 12023: 12026: 1
2018high 2 (2018) · low 0 (2021)2026

Most influential descendants

Showing 5 of 6 · See all
  • K172857Latitud Hip Replacement SystemMeril Healthcare Pvt., Ltd. · 2018 · cites it directly5descendants
  • K180973Libertas Hip Replacement SystemMaxx Orthopedics, Inc. · 2018 · 2 generations on3descendants
  • K253171Libertas Taper Short (TS) Uncemented Femoral Stem (Libertas TS Stem)Maxx Orthopedics, Inc. · 2026 · 3 generations on0descendants
  • K222436Latitud™ Hip Replacement SystemMeril Healthcare Pvt., Ltd. · 2023 · 2 generations on0descendants
  • K192989Libertas E-XLPE Modular LinerMaxx Orthopedics, Inc. · 2020 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K894051Premier-Total HipIntermedics Orthopedics1989—
0 (this device)K960258Natural Hip SystemIntermedics Orthopedics1996—
+1K172857Latitud Hip Replacement SystemMeril Healthcare Pvt., Ltd.2018—
+2K180973Libertas Hip Replacement SystemMaxx Orthopedics, Inc.2018—
+3K253171Libertas Taper Short (TS) Uncemented Femoral Stem (Libertas TS Stem)Maxx Orthopedics, Inc.2026—
+2K222436Latitud™ Hip Replacement SystemMeril Healthcare Pvt., Ltd.2023—
+3K192989Libertas E-XLPE Modular LinerMaxx Orthopedics, Inc.2020—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201820
201910
202010
202310
202610
FIG. 1 — Lineage of K960258, 1989–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JDI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JDI device

  1. #1 K253515 Zimmer Biomet OSS™ Orthopedic Salvage System…score 15.2 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (5)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K894051Premier-Total Hip
Summary page 1
…substantially equivalent to the features employed by the following 1legally marketed predicate devices: n Prem.er Total Hip Stem: Intermedics Orthopaedics Inc. (510(k) #K894051). | Osteonics ODC Cemented Hip Stem: Osteonics Corporation (510(k) number unknown to IOI). | Osteonics ODC Hip Stem: Osteonics…
Intermedics Orthopedics1989—
*—Osteonics ODC Cemented Hip Stem
Named without a submission number
—
*—Osteonics ODC Hip Stem
Named without a submission number
—
*—PFC Cemented Hip Stem
Named without a submission number
—
*—Perfecta IMC Stem
Named without a submission number
—
†K913060Natural Porous Hip SystemIntermedics Orthopedics1991—
†K942330Apr II Femoral Component (Various)Intermedics Orthopedics1994—
†K942406Option ShellIntermedics Orthopedics1994—
†K913208Apr II Non-Porous Hip StemIntermedics Orthopedics1991—

Also cleared against K894051: 1 other device →

What descends from it? (6)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K172857Latitud Hip Replacement SystemMeril Healthcare Pvt., Ltd.20185

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K172857 (Meril Healthcare Pvt., Ltd., 2018) has gone furthest, with 5 descendants of its own.
  • 1 other device also cites its predicate K894051.

How does its category compare?

All JDI devices

JDI Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JDI

1in 2025

2007: 32008: 52009: 32011: 22012: 42013: 32014: 32015: 32016: 42017: 12018: 12019: 22020: 72021: 32022: 32023: 22024: 32025: 12026 (partial year): 2
2007high 7 (2020) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JDI

59in 2024

2007: 81 days median2008: 96 days median2009: 65 days median2012: 167 days median2013: 176 days median2014: 98 days median2015: 190 days median2016: 166 days median2020: 247 days median2021: 162 days median2022: 69 days median2024: 59 days median
2007high 247 (2020) · low 59 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JDI

1in 2025

2007: 262008: 62009: 32010: 32011: 52012: 42013: 112014: 32015: 12016: 52017: 52018: 12019: 12020: 772025: 1
2007high 77 (2020) · low 0 (2021)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JDI

1,644in 2025

2007: 6962008: 8102009: 9642010: 2,0402011: 3,1602012: 5,1222013: 5,2062014: 4,9682015: 4,9062016: 3,9952017: 6,1352018: 6,7282019: 7,4072020: 4,0152021: 3,1702022: 1,9782023: 1,6352024: 1,8212025: 1,644
2007high 7,407 (2019) · low 696 (2007)2025

MAUDE reports naming product code JDI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200738126696
20085966810
20093653964
20100—32,040
20112—53,160
2012416745,122
20133176115,206
201439834,968
2015319014,906
2016416653,995
20171—56,135
20181—16,728
20192—17,407
20207247774,015
2021316203,170
202236901,978
20232—01,635
202435901,821
20251—11,644
20262—0—

What is it indicated for?

1. Patient conditions of noninflammatory degenerative joint disease (NIDJD), e.g.. avascular necrosis, osteoarthritis, and inflammatory joint disease (IJD), e.g., rheumatoid arthritis. 2. Those patients with failed previous surgery where pain, deformity, or dysfunction persists. 3. Revision of previously failed arthroplasty. Total hip replacements may be considered for younger patients if any unequivocal indication outweighs the risks associated with the…

Read the full statement (108 words)

1. Patient conditions of noninflammatory degenerative joint disease (NIDJD), e.g.. avascular necrosis, osteoarthritis, and inflammatory joint disease (IJD), e.g., rheumatoid arthritis.

2. Those patients with failed previous surgery where pain, deformity, or dysfunction persists.

3. Revision of previously failed arthroplasty.

Total hip replacements may be considered for younger patients if any unequivocal indication outweighs the risks associated with the age of the patient (see "Warnings and Precautions"), and modified demands regarding activity and hip joint loading are assured. This includes severely crippled patients with multiple joint involvement, for whom an immediate need of hip mobility leads to an expectation of significant improvement in the quality of their lives.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K960258: Natural Hip System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K960258

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026